Application Note: Highly Specific and Sensitive Methods for In-Tissue and Soluble PD-L1 Detection
Immune checkpoint blockade of the PD-1/PD-L1 pathway has provided the blueprint for cancer immunotherapy. But inconsistencies surrounding the current methods of PD-L1 detection, patient stratification, and consequently, therapeutic efficacy remain. Therefore, alternative methods of detection that are reliable, quantitative, and objective are necessary. In this application note, get acquainted with novel approaches sure to advance your in-tissue and soluble PD-L1 detection workflow.